Choung-Soo Kim Selected Research

CZ0775

12/2013

Dual inhibition of MEK1/2 and EGFR synergistically induces caspase-3-dependent apoptosis in EGFR inhibitor-resistant lung cancer cells via BIM upregulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Choung-Soo Kim Research Topics

Disease

102	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 08/2004
73	Neoplasms (Cancer) 05/2024 - 08/2004
29	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 10/2010
25	Urinary Bladder Neoplasms (Bladder Cancer) 09/2022 - 01/2006
20	Neoplasm Metastasis (Metastasis) 10/2023 - 12/2007
16	Carcinoma (Carcinomatosis) 11/2017 - 12/2010
7	Lymphatic Metastasis 03/2022 - 04/2005
6	Disease Progression 01/2019 - 07/2010
5	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2023 - 05/2010
5	Margins of Excision 01/2021 - 12/2013
5	Breast Neoplasms (Breast Cancer) 01/2015 - 10/2011
4	Extranodal Extension 03/2022 - 04/2005
4	Hypertension (High Blood Pressure) 01/2018 - 02/2010
4	Thrombosis (Thrombus) 07/2017 - 10/2013
4	Chronic Renal Insufficiency 02/2016 - 07/2014
3	Diabetes Mellitus 10/2021 - 02/2014
3	Non-Muscle Invasive Bladder Neoplasms 11/2020 - 01/2014
3	Carcinoma in Situ 08/2019 - 06/2008
3	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 10/2013
3	Pain (Aches) 12/2007 - 06/2006
2	Fibrosis (Cirrhosis) 01/2022 - 01/2021
2	Erectile Dysfunction 10/2021 - 01/2017
2	Back Pain (Backache) 10/2021 - 01/2017
2	Urinary Tract Infections (Urinary Tract Infection) 07/2021 - 09/2004
2	Hemorrhage 01/2021 - 01/2017
2	Lung Neoplasms (Lung Cancer) 01/2019 - 12/2013
2	Hydronephrosis 11/2017 - 01/2006
2	Melanoma (Melanoma, Malignant) 06/2017 - 10/2009
2	Ischemia 01/2017 - 12/2015
2	Necrosis 01/2017 - 01/2014
2	Fatigue 01/2017 - 07/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2015 - 07/2014
2	Sarcoma (Soft Tissue Sarcoma) 12/2014 - 12/2011
2	Pheochromocytoma 07/2014 - 04/2011
2	Urinary Retention 02/2014 - 05/2010
2	Colonic Neoplasms (Colon Cancer) 12/2013 - 10/2009
2	Urethral Stricture 02/2013 - 12/2007
2	Adenocarcinoma 01/2013 - 03/2010

Drug/Important Bio-Agent (IBA)

24	AndrogensIBA 01/2022 - 07/2010
19	Prostate-Specific Antigen (Semenogelase)IBA 10/2023 - 04/2005
12	Hormones (Hormone)IBA 03/2022 - 08/2004
9	enzalutamideIBA 12/2023 - 07/2014
8	Androgen Receptors (Androgen Receptor)IBA 06/2023 - 07/2014
8	Histone Deacetylase InhibitorsIBA 08/2019 - 10/2009
7	Testosterone (Sustanon)FDA Link 03/2021 - 09/2010
7	Docetaxel (Taxotere)FDA Link 08/2019 - 03/2010
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2012
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2013
5	Sunitinib (Sutent)FDA Link 01/2022 - 10/2010
4	AntigensIBA 05/2024 - 10/2011
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 02/2015
4	Tyrosine Kinase InhibitorsIBA 12/2013 - 01/2012
3	Leuprolide (Lupron)FDA LinkGeneric 10/2023 - 12/2010
3	sodium arsenite (sodium metaarsenite)IBA 07/2017 - 01/2014
3	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 01/2012
3	Estrogen ReceptorsIBA 01/2015 - 11/2011
3	Proteins (Proteins, Gene)FDA Link 08/2013 - 12/2010
3	VaccinesIBA 10/2011 - 02/2010
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2022
2	PlatinumIBA 01/2021 - 10/2012
2	Sex Hormone-Binding GlobulinIBA 04/2020 - 01/2018
2	CateninsIBA 10/2019 - 08/2019
2	N1- (3- (dimethylamino)propyl)- N8- hydroxy- 2- ((naphthalene- 1- loxy)methyl)oct- 2- enediamideIBA 08/2019 - 08/2012
2	Pentetic Acid (DTPA)FDA LinkGeneric 06/2019 - 12/2015
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 12/2013
2	Vorinostat FDA Link 01/2019 - 10/2009
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2017 - 11/2015
2	Analgesics (Analgesic Drugs)IBA 04/2017 - 12/2007
2	Platelet-Derived Growth FactorIBA 01/2017 - 12/2015
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017 - 04/2012
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017 - 12/2015
2	AZD 6244IBA 11/2015 - 12/2013
2	CreatinineIBA 06/2015 - 12/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2015 - 01/2014
2	belinostatIBA 05/2015 - 12/2010
2	Cisplatin (Platino)FDA LinkGeneric 01/2015 - 10/2012
2	Interleukin-2 (IL2)IBA 01/2015 - 10/2011
2	Tamsulosin (Flomax)FDA LinkGeneric 02/2014 - 05/2010
2	CaspasesIBA 12/2013 - 08/2012
2	CG 0006IBA 11/2011 - 10/2009
2	nitinolIBA 10/2011 - 12/2007

Therapy/Procedure

50	Therapeutics 05/2024 - 08/2004
50	Prostatectomy (Retropubic Prostatectomy) 03/2022 - 04/2005
29	Castration 05/2024 - 04/2011
23	Cystectomy 09/2022 - 01/2006
19	Nephrectomy 05/2020 - 01/2011
17	Drug Therapy (Chemotherapy) 09/2022 - 08/2007
17	Radiotherapy 01/2022 - 01/2007
9	Lymph Node Excision (Lymph Node Dissection) 09/2022 - 03/2011
9	Nephroureterectomy 04/2017 - 04/2005
5	Stents 07/2021 - 12/2007
4	Adjuvant Chemotherapy 01/2019 - 08/2007
3	Immunotherapy 05/2024 - 05/2013
3	Transurethral Resection of Bladder 11/2020 - 07/2011
2	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2018 - 12/2013
2	Warm Ischemia 04/2017 - 06/2015
2	Adjuvant Radiotherapy 01/2017 - 01/2014
2	Urinary Catheters 01/2017 - 09/2004
2	Critical Care (Surgical Intensive Care) 01/2017 - 06/2015
2	Catheters 02/2014 - 09/2004